Trident Lifeline Limited has made further Investment by acquiring an additional equity stake of 9.04% of TRIDENT MEDIQUIP LIMITED, a subsidiary company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Lifeline Ltd has increased its stake in its subsidiary Trident Mediquip Limited (TML) by acquiring an additional 9.04% equity (7,03,000 shares) from existing shareholders for a cash consideration of approximately Rs. 4.42 crore. Post-acquisition, the company's shareholding in TML has risen from 51% to 60.04%, strengthening its control over the pharmaceutical subsidiary. TML operates in the pharmaceuticals and chemicals industry, with a paid-up capital of Rs. 7.78 crore and turnover of Rs. 21.29 crore in FY25. The transaction qualifies as a related party transaction as TML is an existing subsidiary, and has been carried out at arm's length.
This move gives Trident Lifeline greater control and a larger share of profits from its pharmaceutical subsidiary, though the Rs. 4.42 crore outflow is modest relative to the subsidiary's Rs. 21+ crore turnover. Shareholders should view this as a consolidation of an existing business line rather than a new strategic bet.